The majority of primary tumors had cytoplasmic uPA (91.4%) and/or uPAR (94.1%) expression, while approximately half of the metastatic tumors expressed cytoplasmic uPA (54.2%) and/or uPAR (54.2%) (Table 4). The gene discussed is PLAU; the disease is metastatic neoplasm.